RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma

This study has been completed.

Study NCT00081874 Information provided by M.D. Anderson Cancer Center

First Received: April 23, 2004 Last Updated: September 29, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	October 2004
Estimated Primary Completion Date:	No date given